Cantitate/Preț
Produs

In Vivo Reprogramming in Regenerative Medicine: Stem Cell Biology and Regenerative Medicine

Editat de Açelya Yilmazer
en Limba Engleză Hardback – dec 2017
This new volume reviews current progress on different approaches of in vivo reprogramming technology. Leaders in the field discuss how in vivo cell lineage reprogramming can be used for tissue repair and regeneration in different organs, including brain, spinal cord, pancreas, liver and heart. Recent studies on in vivo cell reprogramming towards pluripotency are reviewed; examples are given to show its potential in regenerative medicine. In each chapter, the regenerative potential of different in vivo reprogramming approaches is discussed in detail. More specifically, how different tissue failures or damages can be treated with this technology is explained. Examples from various animal models are given and the regenerative potential of in vivo reprogramming is compared to that of cell transplantation studies. The last chapter discusses current challenges of these preclinical studies and gives suggestions in order to improve the current strategies. Future directions are indicated for the transition of in vivo reprogramming technology to clinical settings. This is among the first books in the literature which specifically focuses on the in vivo reprogramming technology in regenerative medicine and these chapters collectively cover one of the most important and exciting topics of regenerative medicine.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 54455 lei  38-44 zile
  Springer International Publishing – 31 aug 2018 54455 lei  38-44 zile
Hardback (1) 62520 lei  6-8 săpt.
  Springer International Publishing – dec 2017 62520 lei  6-8 săpt.

Din seria Stem Cell Biology and Regenerative Medicine

Preț: 62520 lei

Preț vechi: 73554 lei
-15% Nou

Puncte Express: 938

Preț estimativ în valută:
11969 12441$ 9923£

Carte tipărită la comandă

Livrare economică 05-19 februarie 25

Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9783319657196
ISBN-10: 3319657194
Pagini: 87
Ilustrații: XVII, 103 p. 15 illus. in color.
Dimensiuni: 155 x 235 mm
Greutate: 0.35 kg
Ediția:1st ed. 2017
Editura: Springer International Publishing
Colecția Humana
Seria Stem Cell Biology and Regenerative Medicine

Locul publicării:Cham, Switzerland

Cuprins

Chapter 1. Introduction to in vivo cell Reprogramming Technology.- Chapter 2. In vivo Reprogramming for Regenerating Insulin-Secreting Cells.- Chapter 3. Direct Reprogramming to Beta Cells.- Chapter 4. In vivo Lineage Reprogramming of Fibroblasts to Cardiomyocytes for Heart Regeneration.- Chapter 5: In vivo cell Reprogramming for Long-term Pluripotency.- Chapter 6: In vivo Transient Reprogramming Towards Pluripotency for Tissue Repair and Regeneration.- Chapter 7. Challenges and Future Perspectives for in vivo Reprogramming Technology.

Notă biografică

Dr. Açelya Yilmazer is as an assistant professor at the Biomedical Engineering Department and the vice director of the Stem Cell Institute of Ankara University. After receiving a BSc in Biology from the Middle East Technical University, she completed her MSc degree in Cancer Immunotherapy at the University of Nottingham and obtained her PhD in the Nanomedicine Lab based in the School of Pharmacy, University College London. She has been selected as the Best Young Investigator in Turkey by the Turkish Society of Medical Biology and Genetics. Her research laboratory focuses on cell reprogramming technologies and development of novel nanomaterial systems for directing cell fate. She is a member of the International Society of Stem Cell Research and the Biomaterials and Tissue Engineering Society of Turkey. 

Textul de pe ultima copertă

There have been significant improvements in the development of cell based therapies; however, current treatment strategies still suffer from some problems: the need for long in vitro culture conditions, inefficient delivery of cells by scaffolds and low incorporation and grafting efficiencies. Therefore, in vivo reprogramming has emerged as a novel treatment technology. In the process of in vivo reprogramming, cells switch to another cell type within the living organism. Leaders in the field discuss how in vivo reprogramming can be used for tissue repair and regeneration in different organs, including pancreas, liver and heart. Furthermore, recent studies on in vivo cell reprogramming towards pluripotency are also reviewed. Current challenges of these preclinical studies are discussed and hypothesis and suggestions are given in order to improve the current strategies to achieve translation into clinic. 

Caracteristici

Reviews the most relevant in vivo reprogramming studies, offering a critical assessment of this potentially powerful technology Explores preclinical studies on animal models providing groundwork for researchers and clinicians to direct the future of in vivo reprogramming and its approaches to clinical settings Contributors culled from top institutions worldwide provide international perspective and expertise